Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 119

    1.

    Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.

    Markowitz M, Nguyen BY, Gotuzzo E, Mendo F, Ratanasuwan W, Kovacs C, Prada G, Morales-Ramirez JO, Crumpacker CS, Isaacs RD, Campbell H, Strohmaier KM, Wan H, Danovich RM, Teppler H; Protocol 004 Part II Study Team.

    J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):350-6.PMID: 19648823 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cytomegalovirus infection causes an increase of arterial blood pressure.

    Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, Zhang J, Crumpacker CS.

    PLoS Pathog. 2009 May;5(5):e1000427. Epub 2009 May 15.PMID: 19436702 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Valganciclovir and human herpesvirus-8.

    Crumpacker CS.

    J Infect Dis. 2008 Jul 1;198(1):6-7. No abstract available. PMID: 18491975 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

    Markowitz M, Nguyen BY, Gotuzzo E, Mendo F, Ratanasuwan W, Kovacs C, Prada G, Morales-Ramirez JO, Crumpacker CS, Isaacs RD, Gilde LR, Wan H, Miller MD, Wenning LA, Teppler H; Protocol 004 Part II Study Team.

    J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):125-33.PMID: 17721395 [PubMed - indexed for MEDLINE]Related articles

    5.

    Primitive hematopoietic cells resist HIV-1 infection via p21.

    Zhang J, Scadden DT, Crumpacker CS.

    J Clin Invest. 2007 Feb;117(2):473-81.PMID: 17273559 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis.

    Wang JF, Meissner A, Malek S, Chen Y, Ke Q, Zhang J, Chu V, Hampton TG, Crumpacker CS, Abelmann WH, Amende I, Morgan JP.

    Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1577-83. Epub 2005 May 27.PMID: 15923319 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Mixed glycoprotein B genotypes of cytomegalovirus and immunosuppression.

    Crumpacker CS.

    Clin Infect Dis. 2004 Jul 15;39(2):162-4. Epub 2004 Jun 23. No abstract available. PMID: 15307022 [PubMed - indexed for MEDLINE]Related articles

    8.

    Use of antiviral drugs to prevent herpesvirus transmission.

    Crumpacker CS.

    N Engl J Med. 2004 Jan 1;350(1):67-8. No abstract available. PMID: 14702430 [PubMed - indexed for MEDLINE]Related articles

    9.

    Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-2003. A 50-year-old Colombian man with fever and seizures.

    Crumpacker CS, Gonzalez RG, Makar RS.

    N Engl J Med. 2003 Aug 21;349(8):789-96. No abstract available. PMID: 12930932 [PubMed - indexed for MEDLINE]Related articles

    10.

    A passive immunotherapy, (PE)HRG214, in patients infected with human immunodeficiency virus: a phase I study.

    Dezube BJ, Proper J, Zhang J, Choy VJ, Weeden W, Morrissey J, Burns EM, Dixon JD, O'Loughlin C, Williams LA, Pickering PJ, Crumpacker CS, Gelder FB.

    J Infect Dis. 2003 Feb 1;187(3):500-3. Epub 2003 Jan 8.PMID: 12552435 [PubMed - indexed for MEDLINE]Related articles

    11.

    Human immunodeficiency virus type 1 nucleocapsid protein nuclear localization mediates early viral mRNA expression.

    Zhang J, Crumpacker CS.

    J Virol. 2002 Oct;76(20):10444-54.PMID: 12239321 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    New anti-HSV therapeutics target the helicase-primase complex.

    Crumpacker CS, Schaffer PA.

    Nat Med. 2002 Apr;8(4):327-8. No abstract available. PMID: 11927930 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cocaine enhances myocarditis induced by encephalomyocarditis virus in murine model.

    Wang JF, Zhang J, Min JY, Sullivan MF, Crumpacker CS, Abelmann WH, Morgan JP.

    Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H956-63.PMID: 11834492 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy.

    Zhang J, Crumpacker CS.

    J Infect Dis. 2001 Nov 15;184(10):1341-4. Epub 2001 Oct 2.PMID: 11679927 [PubMed - indexed for MEDLINE]Related articles

    15.

    Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.

    Lurain NS, Weinberg A, Crumpacker CS, Chou S; Adult AIDS Clinical Trials Group-CMV Laboratories.

    Antimicrob Agents Chemother. 2001 Oct;45(10):2775-80.PMID: 11557468 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: a phase I study.

    Dezube BJ, Dahl TA, Wong TK, Chapman B, Ono M, Yamaguchi N, Gillies SD, Chen LB, Crumpacker CS.

    J Infect Dis. 2000 Aug;182(2):607-10. Epub 2000 Jul 28.PMID: 10915097 [PubMed - indexed for MEDLINE]Related articles

    17.

    Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.

    Zhang JL, Sharma PL, Crumpacker CS.

    Virology. 2000 Mar 15;268(2):251-63.PMID: 10704334 [PubMed - indexed for MEDLINE]Related articles

    19.

    Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories.

    Chou S, Lurain NS, Weinberg A, Cai GY, Sharma PL, Crumpacker CS.

    Antimicrob Agents Chemother. 1999 Jun;43(6):1500-2.PMID: 10348781 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates.

    McSharry JJ, Lurain NS, Drusano GL, Landay AL, Notka M, O'Gorman MR, Weinberg A, Shapiro HM, Reichelderfer PS, Crumpacker CS.

    Antimicrob Agents Chemother. 1998 Sep;42(9):2326-31.PMID: 9736557 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals.

    Schmitz JE, Forman MA, Lifton MA, Concepción O, Reimann KA Jr, Crumpacker CS, Daley JF, Gelman RS, Letvin NL.

    Blood. 1998 Jul 1;92(1):198-206.PMID: 9639517 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry.

    Zhang JL, Choe H, Dezube BJ, Farzan M, Sharma PL, Zhou XC, Chen LB, Ono M, Gillies S, Wu Y, Sodroski JG, Crumpacker CS.

    Virology. 1998 May 10;244(2):530-41.PMID: 9601521 [PubMed - indexed for MEDLINE]Related articles

    23.

    Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.

    Gnann JW Jr, Crumpacker CS, Lalezari JP, Smith JA, Tyring SK, Baum KF, Borucki MJ, Joseph WP, Mertz GJ, Steigbigel RT, Cloud GA, Soong SJ, Sherrill LC, DeHertogh DA, Whitley RJ.

    Antimicrob Agents Chemother. 1998 May;42(5):1139-45.PMID: 9593141 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation.

    Sharma PL, Crumpacker CS.

    J Virol. 1997 Nov;71(11):8846-51. Erratum in: J Virol 1998 Apr;72(4):3504. PMID: 9343245 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels.

    Dezube BJ, Lederman MM, Chapman B, Georges DL, Dogon AL, Mudido P, Reis-Lishing J, Cheng SL, Silberman SL, Crumpacker CS.

    J Infect Dis. 1997 Sep;176(3):807-10.PMID: 9291340 [PubMed - indexed for MEDLINE]Related articles

    26.

    Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.

    Zhang JL, Sharma PL, Li CJ, Dezube BJ, Pardee AB, Crumpacker CS.

    Antimicrob Agents Chemother. 1997 May;41(5):977-81.PMID: 9145855 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    The interleukin-2 fusion protein, DAB389IL-2, inhibits the development of infectious virus in human immunodeficiency virus type 1-infected human peripheral blood mononuclear cells.

    Zhang LJ, Waters CA, Poisson LR, Estis LF, Crumpacker CS.

    J Infect Dis. 1997 Apr;175(4):790-4.PMID: 9086131 [PubMed - indexed for MEDLINE]Related articles

    28.

    Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

    Balfour HH Jr, Fletcher CV, Erice A, Henry WK, Acosta EP, Smith SA, Holm MA, Boivin G, Shepp DH, Crumpacker CS, Eaton CA, Martin-Munley SS.

    Antimicrob Agents Chemother. 1996 Dec;40(12):2721-6.PMID: 9124829 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

    Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):235-46.PMID: 8898668 [PubMed - indexed for MEDLINE]Related articles

    30.

    Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.

    Coombs RW, Welles SL, Hooper C, Reichelderfer PS, D'Aquila RT, Japour AJ, Johnson VA, Kuritzkes DR, Richman DD, Kwok S, Todd J, Jackson JB, DeGruttola V, Crumpacker CS, Kahn J.

    J Infect Dis. 1996 Oct;174(4):704-12.PMID: 8843206 [PubMed - indexed for MEDLINE]Related articles

    31.

    Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.

    Welles SL, Jackson JB, Yen-Lieberman B, Demeter L, Japour AJ, Smeaton LM, Johnson VA, Kuritzkes DR, D'Aquila RT, Reichelderfer PA, Richman DD, Reichman R, Fischl M, Dolin R, Coombs RW, Kahn JO, McLaren C, Todd J, Kwok S, Crumpacker CS.

    J Infect Dis. 1996 Oct;174(4):696-703.PMID: 8843205 [PubMed - indexed for MEDLINE]Related articles

    32.

    AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assay.

    Sharma PL, Chatis PA, Dogon AL, Mayers DL, McCutchan FE, Page C, Crumpacker CS.

    Virology. 1996 Sep 15;223(2):365-9. Erratum in: Virology 1996 Nov 15;225(2):428. PMID: 8806572 [PubMed - indexed for MEDLINE]Related articles

    33.

    Ganciclovir.

    Crumpacker CS.

    N Engl J Med. 1996 Sep 5;335(10):721-9. Review. No abstract available. PMID: 8786764 [PubMed - indexed for MEDLINE]Related articles

    34.

    Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group.

    Japour AJ, Welles S, D'Aquila RT, Johnson VA, Richman DD, Coombs RW, Reichelderfer PS, Kahn JO, Crumpacker CS, Kuritzkes DR.

    J Infect Dis. 1995 May;171(5):1172-9.PMID: 7538548 [PubMed - indexed for MEDLINE]Related articles

    35.

    Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood.

    Zhang LJ, Hanff P, Rutherford C, Churchill WH, Crumpacker CS.

    J Infect Dis. 1995 Apr;171(4):1002-6.PMID: 7706776 [PubMed - indexed for MEDLINE]Related articles

    36.

    Antiviral resistance in clinical practice.

    Kimberlin DW, Crumpacker CS, Straus SE, Biron KK, Drew WL, Hayden FG, McKinlay M, Richman DD, Whitley RJ.

    Antiviral Res. 1995 Apr;26(4):423-38. Review. No abstract available. PMID: 7574544 [PubMed - indexed for MEDLINE]Related articles

    37.

    Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.

    D'Aquila RT, Johnson VA, Welles SL, Japour AJ, Kuritzkes DR, DeGruttola V, Reichelderfer PS, Coombs RW, Crumpacker CS, Kahn JO, Richman DD.

    Ann Intern Med. 1995 Mar 15;122(6):401-8.PMID: 7856987 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    A rapid, direct test for zidovudine susceptibility in clinical isolates of human immunodeficiency virus type 1 (HIV-1) from infected children.

    Lan Y, Japour AJ, Kim S, Welles SL, Crumpacker CS, Cooper E, Al-Attar I, McIntosh K.

    Clin Diagn Virol. 1995 Mar;3(3):259-71.PMID: 15566807 [PubMed]Related articles

    39.

    Criteria for the diagnosis of infective endocarditis.

    von Reyn FC, Arbeit RD, Friedland GH, Crumpacker CS 3rd.

    Clin Infect Dis. 1994 Aug;19(2):368-70. No abstract available. PMID: 7864961 [PubMed - indexed for MEDLINE]Related articles

    40.

    Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group.

    Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS.

    J Infect Dis. 1994 Jun;169(6):1338-41.PMID: 8195614 [PubMed - indexed for MEDLINE]Related articles

    41.

    Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.

    Mayers DL, Japour AJ, Arduino JM, Hammer SM, Reichman R, Wagner KF, Chung R, Lane J, Crumpacker CS, McLeod GX, et al.

    Antimicrob Agents Chemother. 1994 Feb;38(2):307-14.PMID: 8192457 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Two regions of the herpes simplex virus type 1 UL42 protein are required for its functional interaction with the viral DNA polymerase.

    Monahan SJ, Barlam TF, Crumpacker CS, Parris DS.

    J Virol. 1993 Oct;67(10):5922-31.PMID: 8396660 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C.

    Oyan AM, Dolter KE, Langeland N, Goins WF, Glorioso JC, Haarr L, Crumpacker CS.

    J Virol. 1993 May;67(5):2434-41.PMID: 8386261 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

    Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB.

    Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1839-42.PMID: 8446597 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    HIV infection of the BS-1 human stroma cell line: effect on murine hematopoiesis.

    Steinberg HN, Anderson J, Crumpacker CS, Chatis PA.

    Virology. 1993 Mar;193(1):524-7.PMID: 8438590 [PubMed - indexed for MEDLINE]Related articles

    46.

    A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.

    Kahn JO, Lagakos SW, Richman DD, Cross A, Pettinelli C, Liou SH, Brown M, Volberding PA, Crumpacker CS, Beall G, et al.

    N Engl J Med. 1992 Aug 27;327(9):581-7.PMID: 1353607 [PubMed - indexed for MEDLINE]Related articles

    47.

    Resistance of herpesviruses to antiviral drugs.

    Chatis PA, Crumpacker CS.

    Antimicrob Agents Chemother. 1992 Aug;36(8):1589-95. Review. No abstract available. PMID: 1416838 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Mechanism of action of foscarnet against viral polymerases.

    Crumpacker CS.

    Am J Med. 1992 Feb 14;92(2A):3S-7S. Review.PMID: 1371038 [PubMed - indexed for MEDLINE]Related articles

    49.

    Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO.

    Dezube BJ, Pardee AB, Beckett LA, Ahlers CM, Ecto L, Allen-Ryan J, Anisowicz A, Sager R, Crumpacker CS.

    J Acquir Immune Defic Syndr. 1992;5(11):1099-104.PMID: 1403638 [PubMed - indexed for MEDLINE]Related articles

    50.

    Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridization.

    Japour AJ, Chatis PA, Eigenrauch HA, Crumpacker CS.

    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3092-6.PMID: 1707532 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...